Kit Roes appointed Professor of Biostatistics

9 September 2019

Kit Roes has been appointed Professor of Biostatistics at Radboud University/Radboud university medical center, with effect from 1 August 2019. Prior to this appointment, Roes was a Professor of Biostatistics and Clinical Trial Methodology at UMC Utrecht for more than 10 years.

Roes is a biostatistician with extensive experience in statistical applications, research and education. He is a noted expert in the field of clinical studies, methodology and quality of clinical research. His research mainly concentrates on innovative designs and the analysis of clinical research for rare disorders, a focus that fits well with the more individual patient-oriented treatment.
Radboud university medical center
At Radboud university medical center, Prof. Roes and his team will further expand the contribution of biostatistics to research. The combination of innovative designs for (clinical) research and the increasing possibilities offered by prediction and modelling offer the opportunity to evaluate new treatments and techniques more efficiently and thus bring them to the patient more quickly.
Educating students about statistics and biostatistics is extremely important to a number of programmes. Roes will participate in that effort by focusing on the innovations that are taking place in that field, including design and the increasing availability of large data sets.
About Kit Roes
Kit Roes (Nijmegen, 1961) studied mathematics at Radboud University. After graduation, he went to work as an adviser at Philips. He gained more than 10 years’ experience in quality improvement at various companies and in various settings. He earned a PhD in a related context, focusing on new statistical methods for process control.
Biostatistics became his focus when he began working at Organon. He now has more than 15 years’ experience in clinical and non-clinical research into drug development and he has contributed to the development and registration of new drugs in various therapeutic areas. He has been a professor at UMC Utrecht for the past 10 years, where he initiated and led the EU project Asterix about methodologies for clinical studies of rare diseases.
Prof. Roes is chair of the Methodology work group at the College ter Beoordeling van Geneesmiddelen (Medicines Evaluation Board) and a member of the Biostatistics Working Party at the European Medicines Agency. He is also an adviser to various national initiatives, including the Regulatory Science Netwerk Nederland (Regulatory Science Network Netherlands) and the Regie op Registers voor Dure Geneesmiddelen (control of registrations for expensive drugs). In addition, he is a member/chair of various Data Safety and Monitoring Boards.
 

• Want to know more about these subjects? Click on the buttons below for more news.

  Health Evidence